23 articles for thisTarget

---

The following articles (labelled with PubMed ID or TBD) are for your review

PMID	Data	Article Title	Organization
27690432	75	Discovery of Second Generation Reversible Covalent DPP1 Inhibitors Leading to an Oxazepane Amidoacetonitrile Based Clinical Candidate (AZD7986).	Charles River Discovery Research Services
24913985	73	SAR studies of differently functionalized chalcones based hydrazones and their cyclized derivatives as inhibitors of mammalian cathepsin B and cathepsin H.	Kurukshetra University
24642566	17	Acyl hydrazides and triazoles as novel inhibitors of mammalian cathepsin B and cathepsin H.	Kurukshetra University
23252745	86	Development of new cathepsin B inhibitors: combining bioisosteric replacements and structure-based design to explore the structure-activity relationships of nitroxoline derivatives.	University of Ljubljana
19715320	87	Grassystatins A-C from marine cyanobacteria, potent cathepsin E inhibitors that reduce antigen presentation.	University of Florida
19419206	77	Identification of 3-acetyl-2-aminoquinolin-4-one as a novel, nonpeptidic scaffold for specific calpain inhibitory activity.	Ewha Womans University
17535802	91	Inhibition of the activation of multiple serine proteases with a cathepsin C inhibitor requires sustained exposure to prevent pro-enzyme processing.	Merck Research Laboratories
18226527	80	The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K.	Merck Frosst Centre For Therapeutic Research
19665376	48	Design and synthesis of dipeptidyl nitriles as potent, selective, and reversible inhibitors of cathepsin C.	Merck Frosst Canada
18313933	18	Substrate optimization for monitoring cathepsin C activity in live cells.	Genomics Institute of The Novartis Research Foundation
17196818	90	Bicyclic carbamates as inhibitors of papain-like cathepsin proteases.	The Genomics Institute of The Novartis Research Foundation
16647256	16	Dipeptidyl nitriles as human dipeptidyl peptidase I inhibitors.	Arpida
16290936	69	Semicarbazone-based inhibitors of cathepsin K, are they prodrugs for aldehyde inhibitors?	Glaxosmithkline
15896958	32	Acyclic cyanamide-based inhibitors of cathepsin K.	Glaxosmithkline
15837295	55	A structural screening approach to ketoamide-based inhibitors of cathepsin K.	Glaxosmithkline
15780613	28	Novel and potent cyclic cyanamide-based cathepsin K inhibitors.	Glaxosmithkline
15341947	57	Potent and selective P2-P3 ketoamide inhibitors of cathepsin K with good pharmacokinetic properties via favorable P1', P1, and/or P3 substitutions.	Glaxosmithkline
10052963	7	New peptidic cysteine protease inhibitors derived from the electrophilic alpha-amino acid aziridine-2,3-dicarboxylic acid.	Albert-Ludwigs-University of Freiburg
24364476	9	The marine cyanobacterial metabolite gallinamide A is a potent and selective inhibitor of human cathepsin L.	University of California
29272750	15	Substrate-derived triazolo- and azapeptides as inhibitors of cathepsins K and S.	Cnrs Upr 4301
29503024	138	Cathepsin B inhibitors: Further exploration of the nitroxoline core.	University of Ljubljana